Contract HHSO100201300005I
Partner Therapeutics, Inc. · Department Of Health And Human Services · September 19, 2013
Partner Therapeutics, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 19, 2013 for $18.88 million of work in biological product (except diagnostic) manufacturing. It was awarded under full and open competition. The contract has been modified 3 times since the base award It uses order dependent (idv allows pricing arrangement to be determined separately for each order) contract pricing. The most recent modification was on September 28, 2018. If all options are exercised, the contract could reach $605.23 million.
Contract details
- PIID
- HHSO100201300005I
- Award type
- —
- Pricing
- Order Dependent (Idv Allows Pricing Arrangement To Be Determined Separately For Each Order)
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- R&D- Medical: Biomedical (Advanced Development)
- First action
- September 19, 2013
- Latest action
- September 28, 2018
Description
IGF::OT::IGF
Modification timeline
-
September 28, 2018Mod 3$-3.97M
-
June 6, 2018Mod 2IGF::OT::IGFTHE PURPOSE OF THIS MODIFICATION IS TO FINALIZE THE NOVATION AGREEMENT. VIA THIS NOVATION MODIFICATION THE UNITED STATES GOVERNMENT RECOGNIZES THAT$0
-
September 2, 2014Mod 1$0
-
September 19, 2013Base award$22.85M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSO100201300005I?
Contract HHSO100201300005I is a federal contract awarded to Partner Therapeutics, Inc. by Department Of Health And Human Services on September 19, 2013 for $18.88 million of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 3 times since the base award.
Who won contract HHSO100201300005I?
Partner Therapeutics, Inc. won contract HHSO100201300005I from Department Of Health And Human Services.
How much is contract HHSO100201300005I worth?
Contract HHSO100201300005I has obligated $18.88 million to date, with a total potential value of $605.23 million if all options are exercised.